$17.50
2.04% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
GB00BY2Z0H74
Symbol
PRTC

PureTech Health Plc - ADR Stock price

$17.50
-0.30 1.69% 1M
-1.01 5.46% 6M
-0.96 5.20% YTD
-3.85 18.03% 1Y
-12.41 41.49% 3Y
-21.00 54.55% 5Y
-21.00 54.55% 10Y
-21.00 54.55% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.35 2.04%
ISIN
GB00BY2Z0H74
Symbol
PRTC
Industry

Key metrics

Basic
Market capitalization
$422.2m
Enterprise Value
$64.2m
Net debt
positive
Cash
$380.3m
Shares outstanding
239.4m
Valuation (TTM | estimate)
P/E
72.9 | negative
P/S
87.4 | -
EV/Sales
13.3 | -
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
68.8%
Return on Equity
12.9%
ROCE
-24.3%
ROIC
-76.0%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$4.8m | $0.0
EBITDA
$-132.5m | $-140.6m
EBIT
$-136.1m | $-145.7m
Net Income
$53.5m | $-141.5m
Free Cash Flow
$-134.4m
Growth (TTM | estimate)
Revenue
45.1% | -100.0%
EBITDA
6.2% | -6.1%
EBIT
6.9% | -7.1%
Net Income
181.4% | -364.4%
Free Cash Flow
-26.6%
Margin (TTM | estimate)
Gross
-
EBITDA
-2,744.9% | -
EBIT
-2,818.9%
Net
1,108.3% | -
Free Cash Flow
-2,783.4%
More
EPS
$0.2
FCF per Share
$-0.6
Short interest
0.0%
Employees
90
Rev per Employee
$50.0k
Show more

Is PureTech Health Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

PureTech Health Plc - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a PureTech Health Plc - ADR forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a PureTech Health Plc - ADR forecast:

Buy
80%
Hold
20%

Financial data from PureTech Health Plc - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
4.83 4.83
45% 45%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 71 71
34% 34%
1,480%
- Research and Development Expense 69 69
28% 28%
1,438%
-133 -133
6% 6%
-2,744%
- Depreciation and Amortization 3.57 3.57
28% 28%
74%
EBIT (Operating Income) EBIT -136 -136
7% 7%
-2,818%
Net Profit 54 54
181% 181%
1,108%

In millions USD.

Don't miss a Thing! We will send you all news about PureTech Health Plc - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PureTech Health Plc - ADR Stock News

Neutral
Business Wire
about 20 hours ago
BOSTON--(BUSINESS WIRE)--PureTech Announces the Launch of Celea Therapeutics with a Mission to Transform the Treatment of Respiratory Diseases.
Neutral
Business Wire
28 days ago
BOSTON--(BUSINESS WIRE)--PureTech Announces Leadership Transition.
Neutral
Business Wire
about one month ago
BOSTON--(BUSINESS WIRE)--PureTech Announces Board Change.
More PureTech Health Plc - ADR News

Company Profile

PureTech Health Plc is a cross-disciplinary bio-pharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune. It operates through the following segments: Internal, and Affiliates. The Internal segment is advancing a pipeline fuelled by recent discoveries in lymphatics and immune cell trafficking to modulate disease in a tissue-specific manner. The Affiliates segment is comprised of the programmes within PureTech's Affiliates division. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

Head office United Kingdom
CEO Bharatt Chowrira
Employees 90
Founded 2015
Website puretechhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today